Durvalumab 17228-4500
Product NDC
17228-4500- Manufacturer
- Astrazeneca Ab
- Dosage Form
- Injection, Solution
- Product Type
- Drug For Further Processing
- Marketing Start
- January 1, 2020
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Durvalumab | 120 mg/2.4mL |
Packaging Options(2)
330 VIAL in 1 TRAY (17228-4500-1) / 2.4 mL in 1 VIAL
330 VIAL in 1 TRAY (17228-4500-2) / 2.4 mL in 1 VIAL